Objective: The effects of BRL-32872, azimilide and a selective blocker of the delayed rectifier potassium current, E-4031, were Ž . Ž measured at two different basic cycle lengths BCL , 300 and 1000 ms. Calcium channel antagonists of sarcolemmal verapamil and . Ž . nitrendipine and sarcoplasmic reticulum ryanodine membranes were used to investigate whether the inhibition of the calcium current or the calcium release from the sarcoplasmic reticulum could alter the reverse-rate dependence of E-4031 on action potential duration Ž . APD . Methods: Guinea pig isolated papillary muscles were superfused with a Tyrode solution maintained at 378C and stimulated at a BCL of 300 or 1000 ms. The standard microelectrode technique was used to record action potential parameters and to study the effects of Ž . azimilide, BRL-32872 and E-4031. E-4031 was superfused at increasing concentrations 0.01, 0.03, 0.1 and 0.3 mM in the absence or in Ž . Ž . Ž . the presence of verapamil 0.3 mM , nitrendipine 0.03 mM or ryanodine 0.1 mM . Results: BRL-32872 and azimilide induced a self-limited concentration-dependent increase in APD. The effect of BRL-32872 was not dependent on the stimulation frequency whereas the effect of azimilide was significantly reduced at the shorter BCL. E-4031 induced a concentration-dependent increase in APD at both stimulation BCL. The increase in APD was significantly more pronounced in fibres stimulated at a BCL of 1000 ms than in fibres stimulated at a BCL of 300 ms, characterising the reverse-frequency dependent effect of class III antiarrhythmic agents. The reverse-frequency dependence in action potential prolongation induced by E-4031 was significantly reduced in the presence of a low Ž . Ž . Ž . concentration of verapamil 0.3 mM , nitrendipine 0.03 mM , or ryanodine 0.1 mM . Conclusion: The results show that BRL-32872, in contrast to azimilide, does not induce the reverse-rate dependency of action potential prolongation typically produced by class III antiarrhythmic agents such as E-4031. Our results also show that reverse-rate dependency induced by E-4031 can be reduced by the simultaneous administration of a low concentration of a calcium channel antagonist or an inhibitor of the release of calcium from the sarcoplasmic reticulum. It is thus suggested that compounds with a suitable balance of potassium and calcium antagonistic activities may have less adverse effects than purely selective potassium channel blockers. q 1998 Elsevier Science B.V.
Introduction
In species where the delayed rectifier potassium current is the main repolarising current, the cardiac action potential duration is shorter at faster stimulation rates in the physiological range of frequencies. This adaptation to stimulation frequency has been related to the cumulative quency. This effect, termed ''reverse-frequency dependence'', has been observed with most class III antiarrhythmic compounds, e.g. sematilide, dofetilide, E-4031, MK499 w x and d-sotalol 2-7 , and represents an important issue for the clinical use of these agents. The reduced action potential prolonging effect of class III antiarrhythmic compounds at short basic cycle length may decrease drug w x efficacy during ventricular tachyarrhythmias 8 and, perhaps of greater importance, the excessive prolongation of ventricular action potential at slow heart rates may increase the propensity of these agents for inducing early w x afterdepolarisations and torsades de pointes 9 .
Amiodarone is an antiarrhythmic agent which has been w x reported to show a large number of different effects 10 . Focusing on direct cardiac activity, amiodarone, in addition to blocking several potassium currents, inhibits the sodium and calcium currents and also has an antiadrenerw x gic action 11 . When administered chronically, amiodarone prolongs action potential duration and this effect is w x not dependent on the stimulation rate 12 . However, because of its complex mechanism of action, the absence of reverse rate-dependent increase in action potential duration of amiodarone remains unexplained. Recently, we described the electrophysiological effects of a novel antiarrhythmic agent, BRL-32872, and showed that its effects on action potential duration were related to a dual inhibition of the delayed rectifier potassium and of the L-type calw x cium currents 13 . Similarly, Fermini et al. suggested that azimilide, which inhibits the rapid and the slow component of the delayed rectifier potassium current, may also reduce w x the calcium current in cardiac preparations 14 . Because the plateau of the action potential is controlled by a precise equilibrium between many different ionic currents and notably the outward potassium and inward calcium currents, compounds affecting these two conductances may exhibit a frequency dependence different from that observed with pure class III antiarrhythmic agents.
The aim of the present study was to compare the effect of stimulation frequency on the increase in action potential duration induced by BRL-32872, azimilide and a selective blocker of the delayed rectifier potassium current, E-4031 w x 15 . Furthermore, we evaluated whether the reverse-rate dependence of action potential prolongation induced by potassium blockade may be reduced or suppressed by concomitant calcium current antagonism and by the alteration of intracellular calcium handling. To this aim the effects of E-4031 were measured at two different basic cycle lengths, 300 and 1000 ms, in the absence and in the presence of calcium channel antagonists or ryanodine. E-4031 was used in the present study because this compound was shown to block selectively the rapid component of the delayed rectifier, also called the E-4031 sensitive w x component 15 , and to exhibit a clear reverse-frequency dependent increase in action potential duration and effecw x tive refractory period 6 . Since calcium current antagonists may differ in their ability to decrease action potential w x duration in relation to the stimulation frequency 16 , both verapamil and nitrendipine were used to investigate the role of sarcolemmal calcium current inhibition. 
Material and methods

Tissue preparation and recordings
Ž
Protocol
After equilibration, the fibres were randomly assigned to stimulation rate at basic cycle length of either 300 or 1000 ms. Then, stable control action potential parameters Ž . maintained for 30 minutes were determined. Papillary muscles were superfused with increasing concentrations of Ž . Ž BRL-32872 0.3, 1.0, 3.0 and 10.0 mM , azimilide 1.0, . Ž 3.0, 10.0, 30.0 and 100.0 mM or E-4031 0.01, 0.03, 0.1 . and 0.3 mM . Each concentration was applied for 30 minutes, a duration which was considered as the time necessary to reach steady state effect. Only fibres in which the same impalement was maintained during the whole experiments were used for analysis. In a second set of Ž experiments, increasing concentrations of E-4031 0.01, . 0.03, 0.1 and 0.3 mM were tested in the absence or in the Ž . Ž . presence of verapamil 0.3 mM , nitrendipine 0.03 mM Ž . or ryanodine 0.1 mM . These concentrations of verapamil and nitrendipine slightly decreased action potential duration whereas ryanodine slightly prolonged action potential, Ž . but these effects were not significant data not shown . The concentration of ryanodine was however expected to fully inhibit calcium release from the sarcoplasmic reticulum w x 17 . In these experiments, verapamil, nitrendipine or ryanodine was added to the superfusion medium 30 minutes prior to the administration of the first concentration of E-4031 and remained present during the whole experiment. 
Drugs
Ž Ž . w ww Ž BRL-32872 N-3,4-dimethoxyphenyl -N-3 2-3,4- . x x dimethoxyphenyl ethyl propyl -4-nitrobenzamide hydro- . chloride, SmithKline Beecham, Saint-Gregoire, France , Ž azimilide NE10064, Procter and Gamble, synthesised at . Ž SmithKline Beecham, Saint-Gregoire, France , E-4031 N- Ž Ž w Ž . x . 4-1-2-6-methyl-2-pyridyl ethyl -4-piperidyl x . -carbonyl phenyl methanesulfonamide dihydrochloride Ž . dihydrate,
Statistics
Results are presented as mean " SEM. The comparison of the action potential parameters measured at the two cycle lengths was made using the two-tailed unpaired Student's t test. The other statistical comparisons were performed using a two factor repeated measures analysis of variance followed by simple main effects to assess the effect of a drug concentration at a given stimulation frequency and to compare the effect of the two stimulation rates for a given concentration. The ANOVA design consisted of a between group comparison for the effects of stimulation rate on action potential parameters and a within group comparison for the effects of different concentrations of drugs. For parameters in which a simple main effect for drug concentration was found significant, further comparisons of the effects of drugs at a given stimulation rate were made using a within group analysis of variance followed by multiple comparisons using the Sidak procew x dure 18 . For comparisons with equal group sizes, the Greenhouse-Geisser adjustment was used to calculate p value, and for comparisons with unequal group sizes, the Geisser-Greenhouse conservative adjustment was taken w x into consideration 18 . All statistical analyses were performed by means of the microcomputer statistical program Ž CRUNCH 4.0 Crunch Software Corporation, Oakland, . CA . A p value of less than 0.05 was considered as statistically significant.
Results
Effect of stimulation frequency on action potential parameters
Stimulation frequency is well known to influence action potential parameters, principally action potential duration. Table 1 shows the effect of the stimulation frequency on action potential parameters in guinea pig isolated papillary muscle superfused with a normal Tyrode solution. Stimulation frequency had no effect on resting membrane potential and on maximum upstroke velocity. However when the stimulation rate was increased from basic cycle length of Ž . Ž . 1000 ms 1 Hz to 300 ms 3.3 Hz , action potential amplitude was slightly but significantly reduced. The principal effect induced by the increase in stimulation frequency, when basic cycle length was reduced from 1000 to 300 ms, was a significant reduction in action potential duration measured at 30, 50 and 90% of the repolarisation.
ComparatiÕe effects of BRL-32872 and azimilide on action potential duration in guinea pig isolated papillary muscle
BRL-32872 and azimilide have been shown to inhibit the delayed rectifier potassium current and at higher concentrations the L-type calcium current. The results summarised in Table 2 show that in papillary muscles stimulated at basic cycle length of either 1000 ms or 300 ms, both compounds did not significantly change action potential amplitude, resting membrane potential and V except max at the highest concentrations tested. The main effect induced by BRL-32872 and azimilide is a prolongation of the action potential duration at low concentrations with a limitation of this effect when the concentration is increased Ž . further Fig. 1 . Larger concentrations of azimilide than BRL-32872 are required for this bell-shaped response, with the potency difference in fibres stimulated at a basic Ž . cycle length of 1000 ms as shown in Fig. 1 being approximately ten fold. However, the results summarised in Fig. 2 clearly show that azimilide prolonged action Ž potential duration more at slow basic cycle length 1000 . Ž . ms than at fast stimulation frequency 300 ms . In contrast, the increase in action potential duration induced by BRL-32872 was similar at both stimulation frequencies Ž . Fig. 2 . 
Effect of E-4031 in the absence and in the presence of Õerapamil or nitrendipine
Because a calcium blocking action has been involved to explain the electrophysiological effects of BRL-32872 and azimilide, the effects of a pure I blocker, E-4031, adminKr istered at concentrations between 0.01 and 0.3 mM, were investigated in guinea pig isolated papillary muscle in the absence and presence of verapamil or nitrendipine. The Ž . concentrations of verapamil 0.3 mM and nitrendipine Ž . 0.03 mM that were used in these experiments did not significantly change the action potential duration parame-Ž . ters when given alone data not shown . Administered alone, E-4031 had no effect on action potential amplitude, resting membrane potential or maximum upstroke velocity Ž . Table 3 . The main electrophysiological effect of E-4031 was a concentration-dependent increase in action potential Ž . duration at both cycle lengths 300 and 1000 ms; Fig. 3 . The absolute increase in action potential duration was Ž . significantly greater at the longer 1000 ms than the 
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( )Ž . Ž . shorter 300 ms basic cycle length Fig. 3 . This effect, which was observed for all the concentrations of E-4031, illustrated the reverse-frequency dependence of E-4031 on action potential duration.
In the presence of a low concentration of either vera-Ž . Ž . pamil 0.3 mM or nitrendipine 0.03 mM , the main electrophysiological effect induced by E-4031 was a concentration-dependent increase in action potential duration Ž . Table 3 ; Fig. 4A and 4B . The only change observed in the other action potential parameters, was a reduction of the action potential amplitude with the larger concentra-Ž . tions of E-4031 and verapamil Table 3 . In the presence of nitrendipine, E-4031 had no effect on action potential amplitude, resting membrane potential and maximum upstroke velocity. Fig. 4A and 4B clearly illustrate that both calcium channel antagonists reduce the dependence of the increase in action potential duration produced by E-4031 on the stimulation basic cycle length. In the presence of verapamil, the effect of E-4031 was similar at both basic cycle lengths. Although action potential prolongation remained greater in fibres stimulated at 1000 ms than at 300 ms in the presence of nitrendipine, the difference in effect Ž was less than that observed with E-4031 alone compare . Fig. 4B with Fig. 3 . The results obtained with both verapamil and nitrendipine reveal that a low concentration of a calcium blocking agent may blunt the reverse-rate dependence on action potential duration of E-4031. However, verapamil was more effective than nitrendipine in this respect.
Effect of ryanodine on the reÕerse-rate dependence of E-4031 on action potential duration
As evidenced by the results obtained with BRL-32872 on the first hand and with E-4031 in the presence of verapamil and nitrendipine on the other hand, a slight inhibition of the calcium current can reduce the reversefrequency dependence in the increase in action potential Table 3 Effects 
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Values represent mean"SEM of n experiments. Comparison was made using analysis of variance with a Greenhouse-Geisser or the conservative correction followed by multiple comparison with the Sidak procedure. ) p-0.05, ) ) p-0.01, ) ) ) p-0.001 vs. baseline value. duration induced by a class III antiarrhythmic action. However, other mechanisms may also have similar effect. To test this hypothesis further, an additional group of experiments was performed to measure the effect of E-4031 Ž . in the presence of a blocker namely ryanodine of the sarcoplasmic reticulum calcium channel. The results summarised in Table 4 show that the principal effect induced by E-4031 in the presence of ryanodine was a concentra-Ž tion-related prolongation in action potential duration Fig. . 5 . Furthermore, the increase in action potential duration was similar at both the basic cycle lengths of 300 and 1000 Ž . ms Fig. 5 suggesting that the blockade of the ryanodine receptor can abolish the reverse-frequency dependent ef- fect of E-4031. It is interesting to note that ryanodine suppresses the reverse-rate dependency of E-4031 by elevating the response to 300 ms to that of 1000 ms whereas verapamil and nitrendipine reduce the response to 1000 ms to that of 300 ms.
Discussion
Action potential duration is known to be physiologically shorter at fast than at slow stimulation rates in species where the delayed rectifier potassium current is the main repolarising current, and this effect is classically attributed w x to an increased activation in the potassium current 19 . Through a blockade of the cardiac potassium currents, class III antiarrhythmic agents are well known to prolong action potential duration and effective refractory period, an effect which occurs for most agents in a reverse-frequency dependent manner. The reverse-frequency dependence of class III antiarrhythmic agents may limit their therapeutic potential because of reduced effectiveness at rapid frequencies and proarrhythmic potential at slow rates as a consew x quence of excessive action potential prolongation 8 . The results obtained in the present study with E-4031 provide confirmation of the reverse-frequency dependent effect of a typical class III antiarrhythmic agent. A similar range of concentration of E-4031 as the one used in the present Ž . study 0.03 to 1.0 mM has been shown to prolong effecw x tive refractory period in ferret isolated papillary muscle 6 and action potential duration in guinea pig isolated papilw x lary muscle 20 in a reverse-frequency dependent manner. A similar effect in both animal and human studies, has
Similarly, azimilide has been shown to cause a reversefrequency dependent increase in effective refractory period w x in ferret isolated papillary muscle 14 and we observed a similar effect in the present study on action potential duration in guinea pig papillary muscle. In contrast, as shown in Fig. 2 , BRL-32872 did not exhibit any reversefrequency dependence in its ability to increase action potential duration.
The reverse-frequency dependent effect of class III antiarrhythmic agents, which has been shown to occur w x mainly during steady-state conditions 7 , can be attributed Ž . to the blockade of the rapid component I of the Kr w x delayed rectifier potassium current 15,21,22 . This allows Ž . the slowly activating component I to make a greater Ks contribution to repolarisation at shorter basic cycle lengths w x due to its slow deactivation 21 . However, blockade of I Ks may not be sufficient to eliminate completely the reversefrequency dependent increase in action potential duration since azimilide, which still shows a reverse-frequency effect on action potential duration, has been shown to w x block I in several species 23,24 .
Ks
It has been previously shown that calcium blocking agents may inhibit drug-induced afterdepolarisations and excessive action potential prolongation at slow stimulation w x rates 25,26 . The present study shows that low concentrations of calcium channel antagonists reduced the reverserate dependent effect of E-4031 on action potential duration but did not induce any bell shape concentration-dependent effect on action potential duration as obtained with BRL-32872 and azimilide. Indeed, we have shown that increasing concentrations of calcium channel antagonist w x are required to induce such a bell shape effect 27 . In contrast, the present experiments were carried out with a single low concentration of calcium channel antagonist. In addition to an effect on membrane calcium current, calcium channel antagonists have been shown to have other properties; for example, verapamil has been found to inhibit the delayed rectifier potassium current, though at high Ž . w x concentration ) 10 mM 28,29 , and dihydropyridines have been shown to alter the deactivation gating of I but K w x not its amplitude 30 . However, it is unlikely that these properties are involved in the reduction of the reverse-rate dependent effect of E-4031 on action potential duration and it seems reasonable to propose that blockade of membrane calcium current may be responsible for this action.
It is interesting to speculate why a reduction of calcium entry into the cell or inhibition of calcium release from the sarcoplasmic reticulum should reduce the reverse-frequency dependence of class III antiarrhythmic agents on action potential duration. Even if verapamil-and nitrendipine-induced decrease in action potential duration were not significant, it is possible that these small changes have led to a Ž decreased I rI ratio at slow stimulation rate BCL Kr Ks . 1000 ms and thus to a decreased efficacy of E-4031. At . high stimulation rate BCL 300 ms , lack of complete deactivation of I might largely explain action potential Ks shortening and reduction of E-4031 activity which occurs independently of the presence of a calcium current antagonist. Another possibility is that an increase in intracellular calcium concentration within the physiological range may enhance the delayed rectifier potassium current in guinea w x pig cardiac myocytes 31,32 . As the calcium-sensitive component of the delayed rectifier is believed to be I Ks w x 32 , calcium transients, which result mainly from calcium release from the sarcoplasmic reticulum, may be involved in action potential termination particularly at higher frequencies. In the presence of ryanodine, calcium release from the sarcoplasmic reticulum is inhibited and may explain, at least in part, the ryanodine-induced increase in Ž E-4031 efficacy at high stimulation frequency BCL 300 . ms . These hypotheses could account for the observation that calcium current antagonists decrease efficacy of E-4031 at BCL1000 ms and that ryanodine increases efficacy of E-4031 at BCL 300 ms. It is difficult from the present data to speculate whether lack of reverse-rate dependency of BRL-32872 results from the former or the latter mechanism. Whereas it has been found that BRL-32872 inhibits w x the L-type calcium current of heart cells 13 , its effect on calcium release from the sarcoplasmic reticulum remains to be investigated.
The present results in guinea pig isolated ventricular preparations might have clinical relevance since a reversefrequency dependent increase in action potential duration has been observed in humans treated with selective class w x III antiarrhythmic agents such as sematilide 5 . It has already been reported that calcium antagonism may decrease proarrhythmic profile of selective class III antiarw x rhythmic compounds 33-35 . On the other hand, compounds with an intrinsic diversity of electrophysiological w x actions such as amiodarone 12 showed no reversefrequency dependent effect and, in view of our present results, it is tempting to suggest that its ability to inhibit both potassium and calcium currents may at least in part be responsible for this lack of reverse-rate dependency. Therefore, the development of antiarrhythmic agents with a certain diversity of electrophysiological activity, such as potassium and calcium channel antagonism, may lead to compounds with reduced proarrhythmic potential and indeed the results of the present study suggest this might be the case. Thus, the novel antiarrhythmic agent, BRL-32872, w x like amiodarone 12 , prolongs action potential duration to a similar extent at short and long stimulation basic cycle lengths. Whereas amiodarone exhibits very complex elecw x trophysiological and biochemical activities 11,36,37 , BRL-32872 induces a potent blockade of the rapid component of the delayed rectifier potassium current together with a moderate blockade of the L-type calcium current w x 13 . This dual electrophysiological activity has been suggested to be responsible for the low proarrhythmic profile w x of BRL-32872 in vivo 38 . It was indeed shown that the proarrhythmic profile of E-4031 was markedly reduced by w x co-administration of verapamil 38 . Whereas azimilide has Ž a diversity of electrophysiological activity blockade of the rapid and the slow components of the delayed rectifier potassium current and the calcium and the sodium inward w x currents 14,39 , it prolonged action potential duration and effective refractory period more at slow than at fast stimulation frequency both in ferret isolated papillary muscle w x Ž 14 and in guinea pig isolated papillary muscle present . study . This suggests that, in contrast to BRL-32872, which blocks I and I with EC s s 30 nM and 3 mM,
Kr
Ca 50 w x respectively 13 , the balance between the potassium and Ž calcium antagonistic effects of azimilide EC s s 0.3 mM 50 w x and 17.8 mM for I and I , respectively 40 is not Kr Ca adequate to prevent a reverse frequency dependent increase in action potential duration. Moreover, other mechanisms, yet to be identified, might also explain the absence of a reverse-frequency dependent effect of amiodarone and BRL-32872. A further development of the present pharmacological study would consist in a mechanistic analysis that could be performed using several approaches. Indeed a computerised simulation could demonstrate whether rate-dependency of I inhibitors on action potential duration is altered Kr by calcium current inhibition. An alternative approach would be to evaluate whether the I rI ratio changes Kr Ks when the membrane is clamped by action potentials recorded either in the presence or in the absence of calcium channel inhibitors.
In conclusion, the results of the present study confirm that stimulation rate has a significant influence on the effect of class III antiarrhythmic agents, the increase in action potential duration produced by E-4031 being inversely related to cycle length. Our results also demonstrate that in guinea pig isolated papillary muscles, BRL-32872, in contrast to azimilide, induces a similar increase in the action potential duration at fast and slow stimulation rates. This lack of reverse-rate dependency has been recently shown to be relevant in human patients where action potential duration was increased similarly by BRL-Ž . 32872 whatever the cycle length from 300 to 600 ms w x 41 . The fact that BRL-32872 shows no reverse rate dependency, whereas azimilide does, suggests that the balance between potassium and calcium antagonistic activities may be of key value in rate-dependence. However, because the rate dependence of action potential duration is a complex mechanism involving the interaction of many currents, a reduction of the intracellular calcium movement, as evidenced by the effect of ryanodine, or modulation of other currents such as the inward rectifier current, the sodium-calcium exchange current, the slowly inactivating sodium current, the sodium « window» current or the sodium-potassium pump current may also be considered. w x Nevertheless, our results reinforce the hypothesis 27,42 that compounds with a diversity of electrophysiological actions, including potassium and calcium blocking activity, 
